CD47 and acute myeloid leukemia: Another humanized anti-CD47 monoclonal antibody, Hu5F9-G4, will be clinically tested alone for treatment of recurrent/refractory acute myeloid leukemia (trial NCT02678338) and advanced solid malignancy or lymphoma (trial NCT02216409) [212].